GUFIC BIOSCIENCES LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 295 INR | -6.29% |
|
-5.50% | -6.79% |
| 05-30 | Transcript : Gufic Biosciences Limited, Q4 2024 Earnings Call, May 30, 2024 | |
| 05-29 | Gufic Biosciences Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 748B | ||||||
| 598B | ||||||
| 356B | ||||||
| 325B | ||||||
| 283B |
